SCHEMBL6965685

SCHEMBL6965685

Cc1cc(C)cc(SC(C(=O)O)C(=O)O)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TPMT P51580 1/20 0.43
ALDH1A1 P00352 3/20 0.39
LMNA P02545 3/20 0.39
KMT2A Q03164 3/20 0.39
MAPT P10636 2/20 0.39
KDM4E B2RXH2 4/20 0.36
NPSR1 Q6W5P4 2/20 0.36
RXRA P19793 1/20 0.35
RXRB P28702 1/20 0.35
SLC1A3 P43003 1/20 0.34
SLC1A2 P43004 1/20 0.34
SLC1A1 P43005 1/20 0.34
MEN1 O00255 1/20 0.34
ATM Q13315 1/20 0.34
PTGS2 P35354 1/20 0.33
HCAR1 Q9BXC0 1/20 0.33
GPR35 Q9HC97 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HTT P42858 1/20 0.32
CYP2C9 P11712 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6965136 0.70 LMNA (0.46) ALDH1A1LMNAMAPTL3MBTL1CYP2C9
SCHEMBL12286152 0.69 ALDH1A1 (0.36) ALDH1A1KMT2AMAPTKDM4EMEN1
Acetic Acid SCHEMBL27834373 0.67 TPMT (0.63) TPMTALDH1A1KMT2AKDM4ERXRA
SCHEMBL6670264 0.65 TPMT (0.39) TPMTALDH1A1MAPTKDM4ENPSR1
SCHEMBL6481443 0.65 SRC (0.48) TPMTALDH1A1KMT2AKDM4ENPSR1
SCHEMBL27584020 0.65 TPMT (0.42) TPMTALDH1A1KMT2ANPSR1RXRA
SCHEMBL3584535 0.65 TPMT (0.48) TPMTALDH1A1KMT2AMAPTKDM4E
SCHEMBL13453928 0.65 ALDH1A1 (0.33) ALDH1A1
SCHEMBL7238156 0.65 FFAR1 (0.54) TPMTALDH1A1KMT2AKDM4EMEN1
Carbamic Acid SCHEMBL28155281 0.65 TPMT (0.60) TPMTALDH1A1KMT2AKDM4ERXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed